New Approaches for the Management of Hypertension and Cardiovascular Complications

Monday 3rd September 2007

New Approaches for the Management of Hypertension and Cardiovascular Complications

Vienna, Austria

Complications Hypertension plays a pivotal role in the development of a range of cardiovascular events in a progressive continuum of vascular damage. Hence, powerful blood pressure reduction and achievement of aggressive goals are important to protect against long-term cardiovascular morbidity and mortality in high-risk patients.

The recently published revised European Society of Hypertension/European Society of Cardiology guidelines will help broaden our approaches to the management of hypertension. The additional and unique benefits that some antihypertensives offer must be considered in treatment decisions: optimal characteristics include sustained 24-hour blood pressure control and renin-angiotensin system (RAS) inhibition.

In addition, albuminuria is a predictive tool for cardiovascular disease, and powerful blood pressure reduction using angiotensin receptor blockers (ARBs), as well as angiotensin-converting enzyme inhibitors, has been shown to slow the progression of microalbuminuria to macroproteinuria in hypertensive patients at cardiovascular risk. Furthermore, hypertension is perhaps the most controllable among the many modifiable risk factors for stroke and the potential pleiotropic effects of ARBs beyond blood pressure control may contribute to primary and secondary cerebrovascular protection in patients at risk.

Faculty

Symposium Chairmen

• Giuseppe Mancia - Department of Clinical Medicine University of Milan-Bicocca San Gerardo Hospital, Monza-Milan, Italy
• Michael Weber - Office of Scientific Affairs SUNY Downstate College of Medicine, New York, USA

Speakers

• Giuseppe Mancia - Department of Clinical Medicine University of Milan-Bicocca San Gerardo Hospital, Monza-Milan, Italy
• Gordon McInnes - Division of Cardiovascular and Medical Sciences Western Infirmary, Glasgow, UK
• George Bakris - Hypertension Unit University of Chicago-Pritzker School of Medicine, Chicago, USA
• Björn Dahlöf - Department of Medicine Sahlgrenska University Hospital, Gothenburg, Sweden

Agenda

• Welcome and opening remarks - Michael Weber, USA
• Blood pressure lowering: treat to numbers or treat to prevent? - Giuseppe Mancia, Italy
• 24-hour powerful blood pressure lowering: clinical need or pharmacological attribute? - Gordon McInnes, UK
• Renal protection in hypertensive patients at cardiovascular risk - George Bakris, USA
• Stroke prevention in hypertensive patients at cardiovascular risk - Björn Dahlöf, Sweden
• Closing remarks - Giuseppe Mancia, Italy
• Panel Discussion

Start Webcast